- 4-Week # shares bought: 2,941
- 4-Week # shares sold: 8,000
- 12-Week # shares bought: 2,941
- 12-Week # shares sold: 90,283
- 24-Week # shares bought: 2,941
- 24-Week # shares sold: 105,283
More Immunotherapy Buyouts Likely After Kite Sale
This team is playoff-ready and built for the ages.
I've cut a few positions and haven't made any notable buys today.
Buying's good for the acquirers, which should give other companies ideas.
Here's what you need to know now for Tuesday, August 29.